Clinical Trials Browser

Recruiting × Pancreatic Ductal Adenocarcinoma × Clear all

NCT05257993 2026-04-13

Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT07324096 2026-03-27

AI-PACED

Phase NA Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT04975217 2026-03-20

Fecal Microbial Transplants for the Treatment of Pancreatic Cancer

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT07024615 2026-03-13

A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

Phase 1 Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT07199764 2026-03-06

IGNITE

Phase 2 Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT06574620 2026-01-16

ACCELERATE

Phase NA Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT07226154 2025-11-21

PRECEPT

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT06600906 2025-11-12

Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT05365893 2025-04-16

PHL Treatment in Pancreatic Cancer

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT06079346 2024-08-13

STOP-PC

Phase 2/3 Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT06467565 2024-06-21

NALIRIFOX as Induction Therapy in LAPC

Phase 2 Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT05296421 2024-04-10

Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer

Phase NA Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma